ERBB2 and neoplasm: Moreover, analyzing tumor specimens (four TNBC and two ER+ HER2-negative BCs) in which the CAR-T cells were injected, there was wide tumor necrosis at the injection site and macrophage infiltrates within the necrotic areas [113].